Author Question: A nurse assesses a client recovering from a cystoscopy. Which assessment findings should alert the ... (Read 104 times)

pragya sharda · **on:** Jun 25, 2018

A nurse assesses a client recovering from a cystoscopy. Which assessment findings should alert the nurse to urgently contact the health care provider? (Select all that apply.)

a. Decrease in urine output
b. Tolerating oral fluids
c. Prescription for metformin
d. Blood clots present in the urine
e. Burning sensation when urinating

Question 2

A nurse prepares a client for a percutaneous kidney biopsy. Which actions should the nurse take prior to this procedure? (Select all that apply.)

a. Keep the client NPO for 4 to 6 hours.
b. Obtain coagulation study results.
c. Maintain strict bedrest in a supine position.
d. Assess for blood in the client's urine.
e. Administer antihypertensive medications.

rleezy04 · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

ANS: A, D
The nurse should monitor urine output and contact the provider if urine output decreases or becomes absent. The nurse should also assess for blood in the client's urine. The urine may be pink-tinged, but gross bleeding or blood clots should not be present. If bleeding is present, the nurse should urgently contact the provider. Tolerating oral fluids is a positive outcome and does not need intervention. Metformin would be a concern if the client received dye; no dye is used in a cystoscopy procedure. The client may experience a burning sensation when urinating after this procedure; this would not require a call to the provider.

Answer to Question 2

ANS: A, B, E
Prior to a percutaneous kidney biopsy, the client should be NPO for 4 to 6 hours. Coagulation studies should be completed to prevent bleeding after the biopsy. Blood pressure medications should be administered to prevent hypertension before and after the procedure. There is no need to keep the client on bedrest or assess for blood in the client's urine prior to the procedure; these interventions should be implemented after a percutaneous kidney biopsy.